S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology Stock Forecast, Price & News

$19.06
+0.21 (+1.11 %)
(As of 10/15/2021 04:00 PM ET)
Add
Today's Range
$18.61
$19.06
50-Day Range
$15.86
$19.70
52-Week Range
$15.86
$33.85
Volume1,550 shs
Average Volume45,089 shs
Market Capitalization$7.55 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIS
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$19.04 million
Average Daily Volume$100,288.40
Discount/Premium0.02%

ETF Expenses

Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of BIS

Currency Exposure of BIS













ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions

What stocks does MarketBeat like better than ProShares UltraShort Nasdaq Biotechnology?

Wall Street analysts have given ProShares UltraShort Nasdaq Biotechnology a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ProShares UltraShort Nasdaq Biotechnology wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ProShares UltraShort Nasdaq Biotechnology's stock price been impacted by Coronavirus?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $64.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BIS shares have decreased by 70.5% and is now trading at $19.06.
View which stocks have been most impacted by COVID-19
.

When did ProShares UltraShort Nasdaq Biotechnology's stock split? How did ProShares UltraShort Nasdaq Biotechnology's stock split work?

ProShares UltraShort Nasdaq Biotechnology's stock reverse split before market open on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 17th 2020. An investor that had 100 shares of ProShares UltraShort Nasdaq Biotechnology stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include (SNY), Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Quest Diagnostics (DGX), Micron Technology (MU), Pfizer (PFE), (MRNA), Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX).

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS."

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $19.06.

How much money does ProShares UltraShort Nasdaq Biotechnology make?

ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $7.55 million.

What is ProShares UltraShort Nasdaq Biotechnology's official website?

The official website for ProShares UltraShort Nasdaq Biotechnology is www.proshares.com.

Where are ProShares UltraShort Nasdaq Biotechnology's headquarters?

ProShares UltraShort Nasdaq Biotechnology is headquartered at SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States.

How can I contact ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.


This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.